NeuroOne医疗技术第三季度每股收益$（0.03）击败$（0.05）估计，销售额170万美元未达到182万美元估计

NeuroOne Medical Tech (NASDAQ: NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 70 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $1.70 million which missed the analyst consensus estimate of $1.82 million by 6.81 percent. This is a 105.38 percent increase over sales of $825.78 thousand the same period last year.